Is Arcutis Biotherapeutics (ARQT) Offering Value After Recent Share Price Pullback
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
-
If you are wondering whether Arcutis Biotherapeutics at about US$26.20 is offering good value or carrying extra risk, you are not alone.
-
The stock has returned 1.4% over the last 7 days, while the 30 day and year to date returns are both around a 10% decline, set against an 89.2% return over the past year and 58.2% over three years.
-
Recent news flow around Arcutis Biotherapeutics has centered on its position in the pharmaceuticals and biotech space and ongoing interest in its dermatology focused pipeline and commercial execution. These updates help frame how investors are reacting to the stock after a period of…
